Osama Ashry Ahmed Gheith, Nashwa Farouk, Torki Al-Otaibi and Tarek Saied
New-onset diabetes after transplantation [NODAT] is well known complication after organ transplantation especially after solid organ transplantation, bone marrow and hematopoietic stem cells. The incidence of NODAT was observed to be different over post-transplant intervals. It has many risk factors and adverse clinical outcomes include allograft dysfunction, infections, cardiovascular morbidities, and increased mortalities among renal transplant patients. Its management should start before transplantation with special stress on risk factors, modulation of immunosuppressive agents and role of diabetes education before during and after transplantation.
PDFShare this article
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report